As the omicron variant of the COVID19 virus spreads in the United States, scientists have painted a picture of how easily the virus can pass from person to person and escape protection from major doses of the vaccine.
Pfizer, Moderna and Johnson & Johnson provide. Preliminary data suggest that two doses may not be sufficient to protect from variant. “Omicron is assumed to be able to hide some of the immune protection of vaccine-induced antibodies,” said Dr. Anthony Fauci, President Joe Biden’s chief medical adviser said on Sunday. “The somewhat encouraging news is that preliminary data shows that when you receive a recall notice… it raises a level of protection high enough to resist omicron.
The United States is fully immunized, with about one-third also getting booster shots. More than a third have been infected with the virus. Hence, the United States increased to 12.5 million injections in the past week, according to Jeff Zients, the White House coronavirus response coordinator. It is the highest reported number of weekly shootings since May. 7 million of those are booster shots, Zients said.
To date, the COVID19 vaccine has proven to be very effective in preventing hospitalizations and deaths, with unvaccinated people 10 times more likely to be hospitalized if infected. sick. Vaccine manufacturers are optimistic that the vaccines currently approved for use in the United States will also provide some degree of protection against omicron.
To learn more about COVID19 boosters, here’s a tip on how to easily get an appointment and a free ride. Here’s how you’ll soon receive a free COVID19 test kit and details on how to mix and match vaccines.
COVID vaccine booster may be needed to protect against omicron
Fauci said on Sunday that three shots are “optimal care”: “If you want optimal protection, give yourself a booster shot.” His advice comes days after scientists at BioNTech said two doses of a vaccine developed with Pfizer may not be enough against the omicron variant, and three doses in the first two injections and one repeated dose may be needed to restore protection.
“The people who have received two vaccines were not able to significantly prevent infection or any kind of disease [of the new variant],” BioNTech CEO Uğur Şahin said at a press conference Wednesday. . More information is needed to confirm the company’s initial lab results showing that a third dose of the Pfizer vaccine is critical to guard against this variant, Şahin said.
Get Canada and Newfoundland’s top News, Market news, and other worldwide news only on http://nlgazette.com